NASDAQ
Bioasis Technologies Inc. (BIOAF) has a price/sales ratio of 506.36x as of Friday, May 22, 2026. This represents a 1844.74% increase compared to its 12-month average of 26.04x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.